The Indian Institute of Technology Madras (IIT Madras) and Roche Diagnostics International have entered into a strategic partnership to develop ethical artificial intelligence (AI) solutions for healthcare. Formalized through a Memorandum of Understanding (MoU), the collaboration will focus on research and development (R&D) in Responsible AI, ensuring AI technologies used in medical diagnostics and treatment are transparent, accountable, and bias-free.
As part of the agreement, Roche Diagnostics has joined the IITM Centre for Responsible AI (CeRAI) as a Gold Consortium Member, reinforcing its commitment to ethical AI frameworks in medical decision-making.
Ensuring AI Transparency and Safety in Healthcare
At the IITM-CeRAI, Roche Symposium on Responsible AI in Healthcare, held at IIT Madras, Prof. B. Ravindran, Head of CeRAI, emphasized the significance of collaboration between AI researchers and healthcare professionals.
“Roche has an active research program on ethical AI and data management. Working together will help us develop robust and responsible AI systems for healthcare,” he said.
With AI playing an increasing role in diagnostics, treatment planning, and patient care, there is a growing need for ethical and regulatory frameworks to ensure AI-driven solutions are unbiased and reliable.
Also read: AI in Healthcare: Automating Insurance & Patient Care
Industry-Academia Collaboration for AI in Medicine
Roche Diagnostics’ involvement in the initiative aligns with its commitment to AI ethics, patient safety, and data transparency.
Adarsh Srivastava, from Roche’s Data, Analytics, and Research division, noted that this partnership will contribute to ethical AI development, ensuring equitable and safe AI applications in healthcare.
As AI continues to transform the medical field, IIT Madras and Roche aim to pioneer responsible AI solutions, setting benchmarks for trustworthy, explainable, and human-centric AI in healthcare.
